Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6ODL

Crystal structure of GluN2A agonist binding domain with 4-butyl-(S)-CCG-IV

Summary for 6ODL
Entry DOI10.2210/pdb6odl/pdb
DescriptorGlutamate receptor ionotropic, NMDA 2A,Glutamate receptor ionotropic, NMDA 2A, (1S,2R)-2-[(S)-amino(carboxy)methyl]-1-butylcyclopropane-1-carboxylic acid (3 entities in total)
Functional Keywordsnmda receptor, antagonist, transport protein, receptor
Biological sourceRattus norvegicus (Rat)
More
Total number of polymer chains2
Total formula weight63138.37
Authors
Mou, T.C.,Clausen, R.P.,Sprang, S.R.,Hansen, K.B. (deposition date: 2019-03-26, release date: 2020-04-01, Last modification date: 2024-10-30)
Primary citationMaolanon, A.,Papangelis, A.,Kawiecki, D.,Mou, T.C.,Syrenne, J.T.,Yi, F.,Hansen, K.B.,Clausen, R.P.
Stereoselective synthesis of novel 2'-(S)-CCG-IV analogues as potent NMDA receptor agonists.
Eur.J.Med.Chem., 212:113099-113099, 2021
Cited by
PubMed Abstract: We developed a versatile stereoselective route for the synthesis of new 2'-(S)-CCG-IV analogues. The route allows for late stage diversification and thereby provides access to a great variety of conformationally restricted cyclopropyl glutamate analogues. A selection of the 2'-(S)-CCG-IV analogues were evaluated using two-electrode voltage-clamp electrophysiology at recombinant GluN1/GluN2A-D receptors, demonstrating that agonists can be developed with GluN2 subunit-dependent potency and agonist efficacy. We also describe a crystal structure of the GluN2A agonist binding domain in complex with 2'-butyl-(S)-CCG-IV that determines the position of 2'-substituents in (S)-CCG-IV agonists in the glutamate binding site and provides further insight to the structural determinants of their agonist efficacy. The stereoselective synthesis described here enables versatile and straight-forward modifications to diverse analogues of interest for the development of potent subtype-specific NMDA receptor agonists and other applications.
PubMed: 33383257
DOI: 10.1016/j.ejmech.2020.113099
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon